![John Leonard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 20 M $ al 31/05/2026
En la actualidad, John M. Leonard ocupa el cargo de Presidente, Director General y Director de Intellia Therapeutics, Inc. El Dr. Leonard es también Vicepresidente Senior de Investigación y Desarrollo Farmacéutico Global en Abbott Laboratories y forma parte del consejo de administración de otras 6 empresas. Anteriormente, el Dr. Leonard ocupó el cargo de Vicepresidente Senior de Productos Farmacéuticos, Investigación y Desarrollo en Abbott Laboratories, CSO, Vicepresidente Senior de Investigación y Desarrollo Farmacéutico en AbbVie, Inc. y Director Senior de Investigación Clínica en G.H. Besselaar Associates. John M. Leonard se licenció en la Universidad de Wisconsin y se doctoró en la Facultad de Medicina de la Universidad Johns Hopkins.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 1.185.775 ( 0,85 % ) | 17 M $ | 31/05/2026 | |
IQVIA HOLDINGS INC 0,01 % | 23/04/2026 | 16.946 ( 0,01 % ) | 3 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Director Ejecutivo | 01/01/2018 |
| IQVIA HOLDINGS INC. | Director/Miembro de la Junta | 05/02/2015 |
Tyree & D’Angelo Partners Management LP
 Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Inversor de Capital Privado | - |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology Develops biotechnology products | Director/Miembro de la Junta | - |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Director/Miembro de la Junta | - |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Director/Miembro de la Junta | - |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Director/Miembro de la Junta | 13/09/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Miembro de la Junta | - |
3T Biosciences, Inc.
 3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Director/Miembro de la Junta | 25/10/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 17 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Quintiles Transnational Holdings, Inc.
 Quintiles Transnational Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical development services and commercial outsourcing services | Commercial Services |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
G.H. Besselaar Associates | |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tyree & D’Angelo Partners Management LP
Tyree & D’Angelo Partners Management LP Investment ManagersFinance Tyree & D'Angelo Partners invests in lower middle market companies located in the United States and Canada with revenues less than USD 50 million and EBITDA ranging from USD 1 - 5 million. The firm focuses on companies operating in the healthcare, consumer, and business services sectors. It provides financing for buyout stage capital requirements. The firm acquires controlling stake and also makes co-investments. | Finance |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
IFM Therapeutics LLC
IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Health Technology |
IQVIA Holdings, Inc.
 IQVIA Holdings, Inc. BiotechnologyHealth Technology Provides outsourced clinical research and trial, mission critical information, technology, healthcare and patient engagement services | Health Technology |
3T Biosciences, Inc.
3T Biosciences, Inc. BiotechnologyHealth Technology Operates as an immunotherapy company that develops next-generation and transformative therapies for the treatment of solid tumors and immune-mediated diseases | Health Technology |
IFM Cinque, Inc.
IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
IFM Continua, Inc.
IFM Continua, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
IFM Quattro, Inc.
IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
